» Articles » PMID: 35875147

Experimental Validation of an Analytical Program and a Monte Carlo Simulation for the Computation of the Far Out-of-Field Dose in External Beam Photon Therapy Applied to Pediatric Patients

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Jul 25
PMID 35875147
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The out-of-the-field absorbed dose affects the probability of primary second radiation-induced cancers. This is particularly relevant in the case of pediatric treatments. There are currently no methods employed in the clinical routine for the computation of dose distributions from stray radiation in radiotherapy. To overcome this limitation in the framework of conventional teletherapy with photon beams, two computational tools have been developed-one based on an analytical approach and another depending on a fast Monte Carlo algorithm. The purpose of this work is to evaluate the accuracy of these approaches by comparison with experimental data obtained from anthropomorphic phantom irradiations.

Materials And Methods: An anthropomorphic phantom representing a 5-year-old child (ATOM, CIRS) was irradiated considering a brain tumor using a Varian TrueBeam linac. Two treatments for the same planned target volume (PTV) were considered, namely, intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT). In all cases, the irradiation was conducted with a 6-MV energy beam using the flattening filter for a prescribed dose of 3.6 Gy to the PTV. The phantom had natLiF : Mg, Cu, P (MCP-N) thermoluminescent dosimeters (TLDs) in its 180 holes. The uncertainty of the experimental data was around 20%, which was mostly attributed to the MCP-N energy dependence. To calculate the out-of-field dose, an analytical algorithm was implemented to be run from a Varian Eclipse TPS. This algorithm considers that all anatomical structures are filled with water, with the exception of the lungs which are made of air. The fast Monte Carlo code dose planning method was also used for computing the out-of-field dose. It was executed from the dose verification system PRIMO using a phase-space file containing 3x10 histories, reaching an average standard statistical uncertainty of less than 0.2% (coverage factor ) on all voxels scoring more than 50% of the maximum dose. The standard statistical uncertainty of out-of-field voxels in the Monte Carlo simulation did not exceed 5%. For the Monte Carlo simulation the actual chemical composition of the materials used in ATOM, as provided by the manufacturer, was employed.

Results: In the out-of-the-field region, the absorbed dose was on average four orders of magnitude lower than the dose at the PTV. For the two modalities employed, the discrepancy between the central values of the TLDs located in the out-of-the-field region and the corresponding positions in the analytic model were in general less than 40%. The discrepancy in the lung doses was more pronounced for IMRT. The same comparison between the experimental and the Monte Carlo data yielded differences which are, in general, smaller than 20%. It was observed that the VMAT irradiation produces the smallest out-of-the-field dose when compared to IMRT.

Conclusions: The proposed computational methods for the routine calculation of the out-of-the-field dose produce results that are similar, in most cases, with the experimental data. It has been experimentally found that the VMAT irradiation produces the smallest out-of-the-field dose when compared to IMRT for a given PTV.

Citing Articles

Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy.

Morel D, Robert C, Paragios N, Gregoire V, Deutsch E Clin Cancer Res. 2024; 30(11):2317-2332.

PMID: 38477824 PMC: 11145173. DOI: 10.1158/1078-0432.CCR-23-3632.


Validation of an in vivo transit dosimetry algorithm using Monte Carlo simulations and ionization chamber measurements.

Sanchez-Artunedo D, Pie-Padro S, Hermida-Lopez M, Duch-Guillen M, Beltran-Vilagrasa M J Appl Clin Med Phys. 2023; 25(2):e14187.

PMID: 37890864 PMC: 10860462. DOI: 10.1002/acm2.14187.


Complete patient exposure during paediatric brain cancer treatment for photon and proton therapy techniques including imaging procedures.

De Saint-Hubert M, Boissonnat G, Schneider U, Baumer C, Verbeek N, Esser J Front Oncol. 2023; 13:1222800.

PMID: 37795436 PMC: 10546320. DOI: 10.3389/fonc.2023.1222800.


Analytical models for external photon beam radiotherapy out-of-field dose calculation: a scoping review.

Benzazon N, Colnot J, de Kermenguy F, Achkar S, De Vathaire F, Deutsch E Front Oncol. 2023; 13:1197079.

PMID: 37228501 PMC: 10203488. DOI: 10.3389/fonc.2023.1197079.


A Longitudinal Study of Individual Radiation Responses in Pediatric Patients Treated with Proton and Photon Radiotherapy, and Interventional Cardiology: Rationale and Research Protocol of the HARMONIC Project.

Andreassi M, Haddy N, Harms-Ringdahl M, Campolo J, Borghini A, Chevalier F Int J Mol Sci. 2023; 24(9).

PMID: 37176123 PMC: 10178896. DOI: 10.3390/ijms24098416.

References
1.
Majer M, Ambrozova I, Davidkova M, De Saint-Hubert M, Kasabasic M, Knezevic Z . Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study. Med Phys. 2022; 49(4):2672-2683. DOI: 10.1002/mp.15493. View

2.
Schneider C, Newhauser W, Wilson L, Schneider U, Kaderka R, Miljanic S . A descriptive and broadly applicable model of therapeutic and stray absorbed dose from 6 to 25 MV photon beams. Med Phys. 2017; 44(7):3805-3814. DOI: 10.1002/mp.12286. View

3.
Hauri P, Radonic S, Vasi F, Ernst M, Sumila M, Mille M . Development of whole-body representation and dose calculation in a commercial treatment planning system. Z Med Phys. 2021; 32(2):159-172. PMC: 9948842. DOI: 10.1016/j.zemedi.2021.05.001. View

4.
Lloyd S, Gagne I, Bazalova-Carter M, Zavgorodni S . Validation of Varian TrueBeam electron phase-spaces for Monte Carlo simulation of MLC-shaped fields. Med Phys. 2016; 43(6):2894-2903. DOI: 10.1118/1.4949000. View

5.
Rodriguez M, Sempau J, Baumer C, Timmermann B, Brualla L . DPM as a radiation transport engine for PRIMO. Radiat Oncol. 2018; 13(1):256. PMC: 6307123. DOI: 10.1186/s13014-018-1188-6. View